What is the evidence that a systematic and comprehensive NGS-generated profiling of actionable alterations in genes associated with solid tumors should or can inform therapeutic decision-making?

What is the evidence that a systematic and comprehensive NGS-generated profiling of actionable alterations in genes associated with solid tumors should or can inform therapeutic decision-making?

What is the evidence supporting the observation that a systematic and comprehensive NGS-generated profiling of actionable alterations in genes associated with solid tumors should or can inform therapeutic decision-making?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Professor Jeeyun Lee, MD, PhD

Professor Jeeyun Lee, MD, PhD

Department of Hematology and Oncology
Samsung Medical Center
SungKyunKwan University School of Medicine
Seoul, Korea